Seeking AlphaCodex · 实盘不做把握 6/10
北京时间·🕒 发布 23:00:44时区推断·⟳ 抓取 23:04:23·⚡ 决策 07-24 23:05:57 +1m34s·94.9 天前
HCA Healthcare二季度业绩小幅超预期但全年收入、EPS和EBITDA指引高端下调
HCA二季度EPS和收入均略高于预期，但全年收入、EPS及调整后EBITDA指引高端被下调，新增信息正负并存。
📄 原文Seeking Alpha↗ 原文
HCA Healthcare jumps 5% on upbeat results; slashed revenue offsets gains
HCA Healthcare (HCA) rose over 5% on Friday after posting better-than-expected second-quarter results. However, the upb…
不做 HCA Healthcare（HCA.US）
同一HCA二季报催化近72小时已被处理过；本条只是媒体转述，且业绩超预期与全年指引下调相互抵消，盘中已涨约3.3%，不重复建仓。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)
研究档案
🔎 新鲜度:最早出现 2026-07-24 · 扩散 medium · price-in 风险 high ↗
关键理由
- HCA二季度EPS和收入均略高于预期，但全年收入、EPS及调整后EBITDA指引高端被下调，新增信息正负并存。
- 交易时点上HCA.US已在信号到达时盘中上涨约3.3%，市场已即时吸收业绩超预期部分。
- 约10分钟前系统已处理过HCA同一二季报相关催化，本条属于同一事件的媒体转述，不应重复出卡。
主要风险
- 医保交易所覆盖流失带来全年10亿至20亿美元逆风，虽有Medicaid补充支付部分抵消，但后续盈利质量仍需财报会和卖方修模验证。
反向证据
- 做多前查反向 · 来源 kb_search · 日期 2026-07-24 · 影响 none
内部库未命中HCA本身的新研报，但同日医疗服务链条已有财报解读；未发现足以把HCA混合财报升级为追多的新增正面证据。
检索:HCA Healthcare Q2 2026 guidance revenue EPS EBITDA uninsured exchanges Medicaid supplemental payment - 做空前查反向 · 来源 kb_search · 日期 2026-07-24 · 影响 weakens
指引高端下调和医保交易所逆风是真实负面，但二季度经营、现金流和Medicaid补充支付抵消明显，净影响不足以形成强做空催化。
检索:HCA Healthcare Q2 2026 guidance revenue EPS EBITDA uninsured exchanges Medicaid supplemental payment
工具调用 · 历史记录,结果未知(3 种)
- stock_quote · 结果未知
- search_processed_events · 结果未知
- kb_search · 结果未知
原文全文
展开原文 · 1,973 字
HCA Healthcare (HCA) rose over 5% on Friday after posting better-than-expected second-quarter results. However, the upbeat results were slightly offset by the narrowed and reduced full-year guidance.
The hospital chain reported earnings of $7.59 per share, beating estimates by $0.09, on revenue of $20.23B, which came in $490M above Wall Street’s estimates.
The company operated 190 hospitals at the end of the quarter, slightly lower than 191 in the corresponding quarter last year. Same-facility admissions increased 2.5% Y/Y to 575,979.
Adjusted EBITDA increased 4.6% to $4.03B, and cash flows from operating activities totaled $2.34B.
The Nashville, Tennessee-headquartered firm narrowed and reduced the higher end of its revenue estimate to the range of $77B to $79B while it narrowed and reduced its EPS estimate between $28.70 and $30.50. The firm now expects adjusted EBITDA in the range of $15.40B to $16.10B, down slightly from its previous guidance.
During the second quarter, the company's payer mix was impacted by a rise in uninsured patients, largely driven by coverage losses on the health insurance exchanges. The shift had an unfavorable impact on income before income taxes of ~$400M during Q2. It also experienced a service mix shift primarily related to a decline in surgical volume.
On the positive side, HCA witnessed increased benefit from Medicaid Supplemental Payment Programs, growth in admissions, equivalent admissions and ER visits, and improved expense results. During the second quarter, the company recognized ~$400M of incremental net benefit from Medicaid Supplemental Payment Programs, primarily related to the state of Florida program.
For the full year, the company expects a $1B to $2B headwind from health insurance exchanges, partly offset by a $300M to $500M tailwind from Medicaid Supplemental Payment Programs.
HCA has also declared a quarterly dividend of $0.78/share, in line with its previous dividend.
HCA +3.25% to $388.75.
The hospital chain reported earnings of $7.59 per share, beating estimates by $0.09, on revenue of $20.23B, which came in $490M above Wall Street’s estimates.
The company operated 190 hospitals at the end of the quarter, slightly lower than 191 in the corresponding quarter last year. Same-facility admissions increased 2.5% Y/Y to 575,979.
Adjusted EBITDA increased 4.6% to $4.03B, and cash flows from operating activities totaled $2.34B.
The Nashville, Tennessee-headquartered firm narrowed and reduced the higher end of its revenue estimate to the range of $77B to $79B while it narrowed and reduced its EPS estimate between $28.70 and $30.50. The firm now expects adjusted EBITDA in the range of $15.40B to $16.10B, down slightly from its previous guidance.
During the second quarter, the company's payer mix was impacted by a rise in uninsured patients, largely driven by coverage losses on the health insurance exchanges. The shift had an unfavorable impact on income before income taxes of ~$400M during Q2. It also experienced a service mix shift primarily related to a decline in surgical volume.
On the positive side, HCA witnessed increased benefit from Medicaid Supplemental Payment Programs, growth in admissions, equivalent admissions and ER visits, and improved expense results. During the second quarter, the company recognized ~$400M of incremental net benefit from Medicaid Supplemental Payment Programs, primarily related to the state of Florida program.
For the full year, the company expects a $1B to $2B headwind from health insurance exchanges, partly offset by a $300M to $500M tailwind from Medicaid Supplemental Payment Programs.
HCA has also declared a quarterly dividend of $0.78/share, in line with its previous dividend.
HCA +3.25% to $388.75.
决策记录链 · 只追加
每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。
这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。